US Edition
News from Inside Precision Medicine
We’ve assigned a media bias rating of unknown to Inside Precision Medicine. You can read more about our methodology here.
Information about Inside Precision Medicine
Where is Inside Precision Medicine located?Inside Precision Medicine's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Inside Precision Medicine News
Novo Nordisk · DenmarkNovo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer's patients, sending its share price down 10%.See the Story
Novo Nordisk says Alzheimer's drug trial fails, hammering shares
59% Center coverage: 64 sources
Parkinson's DiseaseA common sleep disorder that leaves millions of Americans exhausted may also be quietly increasing their chances of developing Parkinson’s disease — unless they treat it.See the Story
OHSU Study Links Untreated Sleep Apnea to Higher Risk of Parkinson’s
72% Center coverage: 7 sources
Medical · HoustonResearchers at The University of Texas MD Anderson Cancer Center have found that renal medullary carcinoma (RMC) cells use an adaptive mechanism called "myeloid mimicry" to hide from the immune system and promote disease hyperprogression after immunotherapy, highlighting specific targets that overcome treatment resistance in preclinical models.See the Story
Myeloid Mimicry Enables Kidney Tumors to Resist Immunotherapy and Worsen Rapidly, Study Finds
100% Center coverage: 1 sources
